{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:33:36Z","timestamp":1787916816089,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,17]]},"DOI":"10.7759\/cureus.52435","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T14:04:21Z","timestamp":1705500261000},"source":"Crossref","is-referenced-by-count":1,"title":["Alterations of Gastrointestinal Microbe Composition in Various Human Diseases and Its Significance in the Early Diagnosis of Diseases"],"prefix":"10.7759","author":[{"given":"Aman","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Anjankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos WM","year":"2022","unstructured":"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022, 71:1020-32. 10.1136\/gutjnl-2021-326789","journal-title":"Gut"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00036-17","article-title":"The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota","volume":"81","author":"Milani C","year":"2017","unstructured":"Milani C, Duranti S, Bottacini F, et al.. The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol Mol Biol Rev. 2017, 81:e00036-17. 10.1128\/MMBR.00036-17","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2876","article-title":"The interplay between the intestinal microbiota and the brain","volume":"10","author":"Collins SM","year":"2012","unstructured":"Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012, 10:735-42. 10.1038\/nrmicro2876","journal-title":"Nat Rev Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1494-4","article-title":"Antibiotics, gut microbiota, and Alzheimer's disease","volume":"16","author":"Angelucci F","year":"2019","unstructured":"Angelucci F, Cechova K, Amlerova J, Hort J. Antibiotics, gut microbiota, and Alzheimer's disease. J Neuroinflammation. 2019, 16:108. 10.1186\/s12974-019-1494-4","journal-title":"J Neuroinflammation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.190667","article-title":"Gut Microbiota-brain axis","volume":"129","author":"Wang HX","year":"2016","unstructured":"Wang HX, Wang YP. Gut Microbiota-brain axis. Chin Med J (Engl). 2016, 129:2373-80. 10.4103\/0366-6999.190667","journal-title":"Chin Med J (Engl)"},{"key":"ref6","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti M","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015, 28:203-9.","journal-title":"Ann Gastroenterol"},{"key":"ref7","article-title":"Hormonal interactions between gut and brain","volume":"10","author":"Zac-Varghese S","year":"2010","unstructured":"Zac-Varghese S, Tan T, Bloom SR. Hormonal interactions between gut and brain. Discov Med. 2010, 10:543-52.","journal-title":"Discov Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00318","article-title":"Secretory products of the human GI tract microbiome and their potential impact on Alzheimer's disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus","volume":"7","author":"Zhao Y","year":"2017","unstructured":"Zhao Y, Jaber V, Lukiw WJ. Secretory products of the human GI tract microbiome and their potential impact on Alzheimer's disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus. Front Cell Infect Microbiol. 2017, 7:318. 10.3389\/fcimb.2017.00318","journal-title":"Front Cell Infect Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2016.08.019","article-title":"Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly","volume":"49","author":"Cattaneo A","year":"2017","unstructured":"Cattaneo A, Cattane N, Galluzzi S, et al.. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017, 49:60-8. 10.1016\/j.neurobiolaging.2016.08.019","journal-title":"Neurobiol Aging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05336-9","article-title":"Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism","volume":"9","author":"Zarrinpar A","year":"2018","unstructured":"Zarrinpar A, Chaix A, Xu ZZ, et al.. Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism. Nat Commun. 2018, 9:2872. 10.1038\/s41467-018-05336-9","journal-title":"Nat Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3920\/BM2014.0177","article-title":"Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats","volume":"6","author":"Wang T","year":"2015","unstructured":"Wang T, Hu X, Liang S, Li W, Wu X, Wang L, Jin F. Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats. Benef Microbes. 2015, 6:707-17. 10.3920\/BM2014.0177","journal-title":"Benef Microbes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: a systematic review","volume":"21","author":"Payne LE","year":"2017","unstructured":"Payne LE, Gagnon DJ, Riker RR, Seder DB, Glisic EK, Morris JG, Fraser GL. Cefepime-induced neurotoxicity: a systematic review. Crit Care. 2017, 21:276. 10.1186\/s13054-017-1856-1","journal-title":"Crit Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5011-z","article-title":"Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease","volume":"256","author":"Kountouras J","year":"2009","unstructured":"Kountouras J, Boziki M, Gavalas E, et al.. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease. J Neurol. 2009, 256:758-67. 10.1007\/s00415-009-5011-z","journal-title":"J Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12637","article-title":"Therapeutic role of rifampicin in Alzheimer's disease","volume":"72","author":"Yulug B","year":"2018","unstructured":"Yulug B, Hanoglu L, Ozansoy M, Is\u0131k D, Kilic U, Kilic E, Schabitz WR. Therapeutic role of rifampicin in Alzheimer's disease. Psychiatry Clin Neurosci. 2018, 72:152-9. 10.1111\/pcn.12637","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-4858-z","article-title":"Intra-hippocampal D-cycloserine rescues decreased social memory, spatial learning reversal, and synaptophysin levels in aged rats","volume":"235","author":"Portero-Tresserra M","year":"2018","unstructured":"Portero-Tresserra M, Mart\u00ed-Nicolovius M, Tarr\u00e9s-Gatius M, Candalija A, Guillazo-Blanch G, Vale-Mart\u00ednez A. Intra-hippocampal D-cycloserine rescues decreased social memory, spatial learning reversal, and synaptophysin levels in aged rats. Psychopharmacology (Berl). 2018, 235:1463-77. 10.1007\/s00213-018-4858-z","journal-title":"Psychopharmacology (Berl)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/gps.3846","article-title":"A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial","volume":"28","author":"Molloy DW","year":"2013","unstructured":"Molloy DW, Standish TI, Zhou Q, Guyatt G. A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial. Int J Geriatr Psychiatry. 2013, 28:463-70. 10.1002\/gps.3846","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.3.467","article-title":"Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment","volume":"156","author":"Tsai GE","year":"1999","unstructured":"Tsai GE, Falk WE, Gunther J, Coyle JT. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment. Am J Psychiatry. 1999, 156:467-9. 10.1176\/ajp.156.3.467","journal-title":"Am J Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2004.52109.x","article-title":"A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease","volume":"52","author":"Loeb MB","year":"2004","unstructured":"Loeb MB, Molloy DW, Smieja M, et al.. A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease. J Am Geriatr Soc. 2004, 52:381-7. 10.1111\/j.1532-5415.2004.52109.x","journal-title":"J Am Geriatr Soc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2022.02.004","article-title":"Brain-gut-microbiota axis in depression: a historical overview and future directions","volume":"182","author":"Chang L","year":"2022","unstructured":"Chang L, Wei Y, Hashimoto K. Brain-gut-microbiota axis in depression: a historical overview and future directions. Brain Res Bull. 2022, 182:44-56. 10.1016\/j.brainresbull.2022.02.004","journal-title":"Brain Res Bull"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2015.03.016","article-title":"Altered fecal microbiota composition in patients with major depressive disorder","volume":"48","author":"Jiang H","year":"2015","unstructured":"Jiang H, Ling Z, Zhang Y, et al.. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015, 48:186-94. 10.1016\/j.bbi.2015.03.016","journal-title":"Brain Behav Immun"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba8555","article-title":"Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders","volume":"6","author":"Yang J","year":"2020","unstructured":"Yang J, Zheng P, Li Y, et al.. Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders. Sci Adv. 2020, 6:1-11. 10.1126\/sciadv.aba8555","journal-title":"Sci Adv"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201902862","article-title":"Gut microbial signatures can discriminate unipolar from bipolar depression","volume":"7","author":"Zheng P","year":"2020","unstructured":"Zheng P, Yang J, Li Y, et al.. Gut microbial signatures can discriminate unipolar from bipolar depression. Adv Sci (Weinh). 2020, 7:1902862. 10.1002\/advs.201902862","journal-title":"Adv Sci (Weinh)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2019.01.016","article-title":"Exploration of microbiota targets for major depressive disorder and mood related traits","volume":"111","author":"Chung YE","year":"2019","unstructured":"Chung YE, Chen HC, Chou HL, et al.. Exploration of microbiota targets for major depressive disorder and mood related traits. J Psychiatr Res. 2019, 111:74-82. 10.1016\/j.jpsychires.2019.01.016","journal-title":"J Psychiatr Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.09.026","article-title":"Gut microbiota composition in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives","volume":"75","author":"Coello K","year":"2019","unstructured":"Coello K, Hansen TH, S\u00f8rensen N, Munkholm K, Kessing LV, Pedersen O, Vinberg M. Gut microbiota composition in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives. Brain Behav Immun. 2019, 75:112-8. 10.1016\/j.bbi.2018.09.026","journal-title":"Brain Behav Immun"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2019.12.014","article-title":"Gut microbial changes of patients with psychotic and affective disorders: a systematic review","volume":"234","author":"Vindegaard N","year":"2021","unstructured":"Vindegaard N, Speyer H, Nordentoft M, Rasmussen S, Benros ME. Gut microbial changes of patients with psychotic and affective disorders: a systematic review. Schizophr Res. 2021, 234:1-10. 10.1016\/j.schres.2019.12.014","journal-title":"Schizophr Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9574","article-title":"Altered gut microbiota associated with symptom severity in schizophrenia","volume":"8","author":"Li S","year":"2020","unstructured":"Li S, Zhuo M, Huang X, et al.. Altered gut microbiota associated with symptom severity in schizophrenia. PeerJ. 2020, 8:e9574. 10.7717\/peerj.9574","journal-title":"PeerJ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.44","article-title":"Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism","volume":"21","author":"Zheng P","year":"2016","unstructured":"Zheng P, Zeng B, Zhou C, et al.. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol Psychiatry. 2016, 21:786-96. 10.1038\/mp.2016.44","journal-title":"Mol Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2014.10.050","article-title":"Intracerebroventricular injection of propionic acid, an enteric metabolite implicated in autism, induces social abnormalities that do not differ between seizure-prone (FAST) and seizure-resistant (SLOW) rats","volume":"278","author":"Shultz SR","year":"2015","unstructured":"Shultz SR, Aziz NA, Yang L, Sun M, MacFabe DF, O'Brien TJ. Intracerebroventricular injection of propionic acid, an enteric metabolite implicated in autism, induces social abnormalities that do not differ between seizure-prone (FAST) and seizure-resistant (SLOW) rats. Behav Brain Res. 2015, 278:542-8. 10.1016\/j.bbr.2014.10.050","journal-title":"Behav Brain Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.112374","article-title":"Analysis of gut mycobiota in first-episode, drug-na\u00efve Chinese patients with schizophrenia: a pilot study","volume":"379","author":"Zhang X","year":"2020","unstructured":"Zhang X, Pan LY, Zhang Z, Zhou YY, Jiang HY, Ruan B. Analysis of gut mycobiota in first-episode, drug-na\u00efve Chinese patients with schizophrenia: a pilot study. Behav Brain Res. 2020, 379:112374. 10.1016\/j.bbr.2019.112374","journal-title":"Behav Brain Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.04.017","article-title":"Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response","volume":"192","author":"Schwarz E","year":"2018","unstructured":"Schwarz E, Maukonen J, Hyyti\u00e4inen T, et al.. Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response. Schizophr Res. 2018, 192:398-403. 10.1016\/j.schres.2017.04.017","journal-title":"Schizophr Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1890","article-title":"Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort","volume":"37","author":"Flowers SA","year":"2017","unstructured":"Flowers SA, Evans SJ, Ward KM, McInnis MG, Ellingrod VL. Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort. Pharmacotherapy. 2017, 37:261-7. 10.1002\/phar.1890","journal-title":"Pharmacotherapy"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.03.049","article-title":"Gut microbiota in patients with irritable bowel syndrome-a systematic review","volume":"157","author":"Pittayanon R","year":"2019","unstructured":"Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, Moayyedi P. Gut microbiota in patients with irritable bowel syndrome-a systematic review. Gastroenterology. 2019, 157:97-108. 10.1053\/j.gastro.2019.03.049","journal-title":"Gastroenterology"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57468-y","article-title":"Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome","volume":"10","author":"Sundin J","year":"2020","unstructured":"Sundin J, Aziz I, Nordlander S, et al.. Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome. Sci Rep. 2020, 10:593. 10.1038\/s41598-020-57468-y","journal-title":"Sci Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033387","article-title":"Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants","volume":"7","author":"Sellitto M","year":"2012","unstructured":"Sellitto M, Bai G, Serena G, et al.. Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One. 2012, 7:e33387. 10.1371\/journal.pone.0033387","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0415-6","article-title":"Gut microbiota trajectory in early life may predict development of celiac disease","volume":"6","author":"Olivares M","year":"2018","unstructured":"Olivares M, Walker AW, Capilla A, et al.. Gut microbiota trajectory in early life may predict development of celiac disease. Microbiome. 2018, 6:36. 10.1186\/s40168-018-0415-6","journal-title":"Microbiome"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1101\/gr.126573.111","article-title":"Genomic analysis identifies association of Fusobacterium with colorectal carcinoma","volume":"22","author":"Kostic AD","year":"2012","unstructured":"Kostic AD, Gevers D, Pedamallu CS, et al.. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012, 22:292-8. 10.1101\/gr.126573.111","journal-title":"Genome Res"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30486","article-title":"Periodontal disease, tooth loss and colorectal cancer risk: results from the Nurses' Health Study","volume":"140","author":"Momen-Heravi F","year":"2017","unstructured":"Momen-Heravi F, Babic A, Tworoger SS, et al.. Periodontal disease, tooth loss and colorectal cancer risk: results from the Nurses' Health Study. Int J Cancer. 2017, 140:646-52. 10.1002\/ijc.30486","journal-title":"Int J Cancer"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1343","article-title":"Colonization of the human gut by E. coli and colorectal cancer risk","volume":"20","author":"Bonnet M","year":"2014","unstructured":"Bonnet M, Buc E, Sauvanet P, et al.. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res. 2014, 20:859-67. 10.1158\/1078-0432.CCR-13-1343","journal-title":"Clin Cancer Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis M","year":"2016","unstructured":"Llopis M, Cassard AM, Wrzosek L, et al.. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut. 2016, 65:830-9. 10.1136\/gutjnl-2015-310585","journal-title":"Gut"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol H","year":"2008","unstructured":"Sokol H, Pigneur B, Watterlot L, et al.. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008, 105:16731-6. 10.1073\/pnas.0804812105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel C","year":"2020","unstructured":"de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020, 8:180-90. 10.1016\/S2214-109X(19)30488-7","journal-title":"Lancet Glob Health"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.435","article-title":"Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota","volume":"118","author":"Goedert JJ","year":"2018","unstructured":"Goedert JJ, Hua X, Bielecka A, et al.. Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota. Br J Cancer. 2018, 118:471-9. 10.1038\/bjc.2017.435","journal-title":"Br J Cancer"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10030083","article-title":"The complex interplay between chronic inflammation, the microbiome, and cancer: understanding disease progression and what we can do to prevent it","volume":"10","author":"Armstrong H","year":"2018","unstructured":"Armstrong H, Bording-Jorgensen M, Dijk S, Wine E. The complex interplay between chronic inflammation, the microbiome, and cancer: understanding disease progression and what we can do to prevent it. Cancers (Basel). 2018, 10:83. 10.3390\/cancers10030083","journal-title":"Cancers (Basel)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15081747","article-title":"Breast cancer and its relationship with the microbiota","volume":"15","author":"Fern\u00e1ndez MF","year":"2018","unstructured":"Fern\u00e1ndez MF, Reina-P\u00e9rez I, Astorga JM, Rodr\u00edguez-Carrillo A, Plaza-D\u00edaz J, Fontana L. Breast cancer and its relationship with the microbiota. Int J Environ Res Public Health. 2018, 15:1747. 10.3390\/ijerph15081747","journal-title":"Int J Environ Res Public Health"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.09.003","article-title":"Gut microbiota and cancer: how gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy","volume":"143","author":"Gori S","year":"2019","unstructured":"Gori S, Inno A, Belluomini L, Bocus P, Bisoffi Z, Russo A, Arcaro G. Gut microbiota and cancer: how gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy. Crit Rev Oncol Hematol. 2019, 143:139-47. 10.1016\/j.critrevonc.2019.09.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318556","article-title":"International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis","volume":"68","author":"Scott AJ","year":"2019","unstructured":"Scott AJ, Alexander JL, Merrifield CA, et al.. International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis. Gut. 2019, 68:1624-32. 10.1136\/gutjnl-2019-318556","journal-title":"Gut"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010038","article-title":"Gut microbiota and cancer: from pathogenesis to therapy","volume":"11","author":"Vivarelli S","year":"2019","unstructured":"Vivarelli S, Salemi R, Candido S, et al.. Gut microbiota and cancer: from pathogenesis to therapy. Cancers (Basel). 2019, 11:38. 10.3390\/cancers11010038","journal-title":"Cancers (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/175019-alterations-of-gastrointestinal-microbe-composition-in-various-human-diseases-and-its-significance-in-the-early-diagnosis-of-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:03Z","timestamp":1707509583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/175019-alterations-of-gastrointestinal-microbe-composition-in-various-human-diseases-and-its-significance-in-the-early-diagnosis-of-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.52435","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,17]]}}}